Ticker: IMMX

Immix Biopharma, Inc. (NASDAQ: IMMX) is a clinical-stage biopharmaceutical company focused on developing cell therapies, particularly for AL Amyloidosis. As of June 30, 2025, the company reported significant financial metrics and activity updates revealing both challenges and opportunities. Key P...